|
|
||||||||
Papers In Press, published online ahead of print October 1, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105-2794
Corresponding Author: suzanne.jackowski{at}stjude.org
Pantothenate kinase (PanK) is thought to catalyze the first rate-limiting step in Coenzyme A (CoA) biosynthesis. The full-length cDNA encoding the human PanK1
Revised on September 3, 2003
Accepted on September 16, 2003
PPAR
controls the intracellular coenzyme A concentration via regulation of PANK1
gene expression
protein was isolated and the complete human PANK1 gene structure was determined. Bezafibrate, a hypolipidemic drug and a PPAR
agonist, specifically increased hPANK1
mRNA expression in human hepatoblastoma (HepG2) cells as a function of time and dose of the drug, compared to hPANK1
, hPANK2 and hPANK3, which did not significantly increase. Four putative PPAR
response elements were identified in the PANKI
promoter and bezafibrate stimulated hPANK1
promoter activity, but did not alter the mRNA half-life. Increased hPANK1
mRNA resulted in higher hPanK1 protein, localized in the cytoplasm, and elevated PanK enzyme activity. The enhanced hPANK1
gene expression translated into increased activity of the CoA biosynthetic pathway and established a higher steady-state CoA level in HepG2 cells. These data are consistent with a key role for PanK1
in the control of cellular CoA content and point to the PPAR
transcription factor as a major factor that governs hepatic CoA levels by specific modulation of PANK1
gene expression.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. J. McCarthy, J. L. Andrews, E. L. McDearmon, K. S. Campbell, B. K. Barber, B. H. Miller, J. R. Walker, J. B. Hogenesch, J. S. Takahashi, and K. A. Esser Identification of the circadian transcriptome in adult mouse skeletal muscle Physiol Genomics, September 11, 2007; 31(1): 86 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. De Souza, P. D. Cornwell, X. Dai, M. J. Caguyong, and R. G. Ulrich Agonists of the Peroxisome Proliferator-Activated Receptor Alpha Induce a Fiber-Type-Selective Transcriptional Response in Rat Skeletal Muscle Toxicol. Sci., August 1, 2006; 92(2): 578 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-M. Zhang, C. O. Rock, and S. Jackowski Biochemical Properties of Human Pantothenate Kinase 2 Isoforms and Mutations Linked to Pantothenate Kinase-associated Neurodegeneration J. Biol. Chem., January 6, 2006; 281(1): 107 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-M. Zhang, C. O. Rock, and S. Jackowski Feedback Regulation of Murine Pantothenate Kinase 3 by Coenzyme A and Coenzyme A Thioesters J. Biol. Chem., September 23, 2005; 280(38): 32594 - 32601. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Brand and E. Strauss Characterization of a New Pantothenate Kinase Isoform from Helicobacter pylori J. Biol. Chem., May 27, 2005; 280(21): 20185 - 20188. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |